Treatment with ixekizumab does not interfere with the efficacy of tetanus and pneumococcal vaccines in healthy subjects

Authors
Category Primary study
JournalJournal of Investigative Dermatology
Year 2017
This article has no abstract
Epistemonikos ID: af38524fd359324fe8f6ec7cc1e0ff7d91dfb1de
First added on: Feb 08, 2025